Indraprastha Medical Corporation Limited has submitted a regulatory disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding a change in Key Managerial Personnel.
Committee Membership Impact
Mr. Pattabhiraman was a member of the Stakeholders Relationship Committee. With his cessation as Managing Director, he also ceased to be a member of the Stakeholders Relationship Committee.
Background and Tenure Details
The shareholders at the Annual General Meeting held on 24th September, 2024, had re-appointed Mr. Shivakumar Pattabhiraman as Managing Director of the Company for a period of 2 (two) years. His term was effective from 5th November, 2024 to 4th November, 2026. His present term as Managing Director ended on 4th November, 2026 as scheduled.
Financial Impact
No financial impact quantified in the disclosure.